G9065
HCPCSOnc dx nsclc stg3a no progre
Official HCPCS Level II long descriptor
Oncology; disease status; limited to non-small cell lung cancer; extent of disease initially established as stage iii a (prior to neo-adjuvant therapy, if any) with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)
HCPCS Level II code G9065 is maintained by CMS and is active in the current quarterly release.
Short descriptor
Onc dx nsclc stg3a no progre
Added to HCPCS: 2006-01-01
Nearby codes in G9
- G9057Onc pract mgmt differs trial
- G9058Onc prac mgmt disagree w/gui
- G9059Onc prac mgmt pt opt alterna
- G9060Onc prac mgmt dif pt comorb
- G9061Onc prac cond noadd by guide
- G9062Onc prac guide differs nos
- G9063Onc dx nsclc stgi no progres
- G9064Onc dx nsclc stg2 no progres
- G9066Onc dx nsclc stg3b-4 metasta
- G9067Onc dx nsclc dx unknown nos
- G9068Onc dx sclc/nsclc limited
- G9069Onc dx sclc/nsclc ext at dx
- G9070Onc dx sclc/nsclc ext unknwn
- G9071Onc dx brst stg1-2b hr,nopro
- G9072Onc dx brst stg1-2 noprogres
- G9073Onc dx brst stg3-hr, no pro
Where this code sits
Krasyn Codes for Chrome
Review coding suggestions beside a validated web workflow. Private pilot.
Request pilot accessSource
HCPCS Level II July 2026 quarterly update. Centers for Medicare & Medicaid Services (CMS), “July 2026 Alpha-Numeric HCPCS File” (HCPC2026_JUL_ANWEB_06172026.txt). Download the original file from cms.gov. Public domain (US Government work). Descriptors, billable flags and instructional notes on this page are reproduced from that file without modification. Krasyn adds no clinical guidance.